Stay updated on Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check29 days agoChange DetectedA sitewide notice appears announcing NIH’s website transition and explaining that “Super Intelligence” may be used in place of “Artificial Intelligence” during the transition.SummaryDifference0.4%

- Check36 days agoChange DetectedThe ClinicalTrials.gov footer now identifies site release v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check43 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study record history page appears unchanged, with the same version table and study details visible.SummaryDifference0.1%

Stay in the know with updates to Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bioavailability of SC Pembrolizumab in Solid Tumors Clinical Trial page.